PBYI
PUMA BIOTECHNOLOGY, INC.
NASDAQ · Healthcare · Biotechnology · US
$9.60
+0.84%Next report
Analyst consensus
- Next report date
- Nov 5, 2026
- EPS estimate
- $0.11
- Revenue estimate
- $57.5M
Latest reported
- Last report date
- Aug 6, 2026
- EPS actual
- $0.19
- EPS estimate
- $0.04
- Revenue actual
- $56.5M
- Revenue estimate
- $53.0M
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 11
- EPS misses (12Q)
- 1
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +153.5%
- Revenue beats (12Q)
- 8
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 6, 2026 | $0.04 | $0.19 | Beat 375.00% | $56.5M |
| May 7, 2026 | -$0.13 | -$0.04 | Beat 69.23% | $44.8M |
| Nov 6, 2025 | $0.09 | $0.21 | Beat 133.33% | $54.5M |
| Aug 7, 2025 | $0.11 | $0.15 | Beat 36.36% | $52.4M |
| May 8, 2025 | $0.02 | $0.10 | Beat 400.00% | $46.0M |
| Feb 27, 2025 | $0.10 | $0.43 | Beat 330.00% | $59.1M |
| Nov 7, 2024 | $0.35 | $0.41 | Beat 17.14% | $80.5M |
| Aug 1, 2024 | -$0.10 | -$0.05 | Beat 50.00% | $47.1M |
| May 2, 2024 | -$0.16 | -$0.05 | Beat 68.75% | $43.8M |
| Feb 29, 2024 | $0.30 | $0.26 | Miss -13.33% | $72.2M |
| Nov 2, 2023 | $0.08 | $0.12 | Beat 50.00% | $56.1M |
| Aug 3, 2023 | $0.07 | $0.10 | Beat 42.86% | $54.6M |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 5, 2026